Get all your news in one place.
100's of premium titles.
One app.
Start reading
Radio France Internationale
Radio France Internationale
National
RFI

France to start covering cost of weight-loss drugs for obese patients

Prescriptions of Wegovy and Mounjaro will soon be reimbursed in France for severely obese patients.
Prescriptions of Wegovy and Mounjaro will soon be reimbursed in France for severely obese patients. © Victoria Klesty/Reuters

France's public health system will soon start to cover most of the cost of weight-loss drugs Wegovy and Mounjaro for severely obese patients.

The government has signed off on partially reimbursing patients who are prescribed Novo Nordisk's Wegovy and Eli Lilly's Mounjaro injectable GLP-1 medications, which have gained widespread attention as anti-obesity treatments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.